<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Frequency Therapeutics To Contact Him Directly To Discuss Their OptionsNew York, New York–(Newsfile Corp. – July 17, 2021) – Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Frequency Therapeutics, Inc. (“Frequency” or the “Company”) (NASDAQ: FREQ) and reminds investors of the August 2, 2021 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you suffered losses exceeding $50,000 investing in Frequency stock or options…
...read full article on Newsfile Corp
